Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionLegacy Private Trust Co.
Latest Disclosed Ownership4,596 shares
Latest Disclosed Value $ 1,617,102
Legacy Private Trust Co. reports 26.23% decrease in ownership of AMGN / Amgen Inc.

On April 7, 2026 - Legacy Private Trust Co. filed a 13F-HR form disclosing ownership of 4,596 shares of Amgen Inc. (MX:AMGN) valued at $1,617,102 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 6,230 shares of Amgen Inc.. This represents a change in shares of -26.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F AMGEN COM 031162100 4,596 -1,634 -26.23 1,617 -20.70 0.0550
2026-01-08 2025-12-31 13F AMGEN COM 031162100 6,230 -1,861 -23.00 2,039 -10.69 0.1197
2025-10-08 2025-09-30 13F AMGEN COM 031162100 8,091 -1,365 -14.44 2,283 -13.52 0.1361
2025-07-08 2025-06-30 13F AMGEN COM 031162100 9,456 1,134 13.63 2,640 1.85 0.1705
2025-04-04 2025-03-31 13F AMGEN COM 031162100 8,322 606 7.85 2,593 28.89 0.1782
2025-01-08 2024-12-31 13F AMGEN COM 031162100 7,716 784 11.31 2,011 -9.94 0.1316
2024-10-07 2024-09-30 13F AMGEN COM 031162100 6,932 122 1.79 2,234 4.98 0.1501
2024-07-12 2024-06-30 13F AMGEN COM 031162100 6,810 -170 -2.44 2,128 7.21 0.1512
2024-04-10 2024-03-31 13F AMGEN COM 031162100 6,980 4,654 200.09 1,985 196.56 0.1451
2024-01-10 2023-12-31 13F AMGEN COM 031162100 2,326 0 0.00 670 7.04 0.0533
2023-10-11 2023-09-30 13F AMGEN COM 031162100 2,326 0 0.00 625 21.12 0.0538
2023-07-07 2023-06-30 13F AMGEN COM 031162100 2,326 -84 -3.49 516 -11.34 0.0427
2023-04-12 2023-03-31 13F AMGEN COM 031162100 2,410 -77 -3.10 583 -10.87 0.0497
2023-01-19 2022-12-31 13F/A-1 AMGEN COM 031162100 2,487 0 0.00 653 16.40 0.0590
2023-01-06 2022-12-31 13F AMGEN COM 031162100 2,487 0 1 0.0334
2022-10-06 2022-09-30 13F AMGEN COM 031162100 2,487 -55 -2.16 561 -9.22 0.0532
2022-07-07 2022-06-30 13F AMGEN COM 031162100 2,542 0 0.00 618 0.49 0.0553
2022-04-11 2022-03-31 13F AMGEN COM 031162100 2,542 -270 -9.60 615 -2.84 0.0477
2022-01-12 2021-12-31 13F AMGEN COM 031162100 2,812 0 0.00 633 5.85 0.0475
2021-10-12 2021-09-30 13F AMGEN COM 031162100 2,812 -490 -14.84 598 -25.71 0.0484
2021-07-09 2021-06-30 13F AMGEN COM 031162100 3,302 -217 -6.17 805 -8.11 0.0679
2021-04-09 2021-03-31 13F AMGEN COM 031162100 3,519 -584 -14.23 876 -7.10 0.0790
2021-01-12 2020-12-31 13F AMGEN COM 031162100 4,103 -1,930 -31.99 943 -38.49 0.0891
2020-10-14 2020-09-30 13F AMGEN COM 031162100 6,033 -133 -2.16 1,533 5.43 0.1583
2020-07-09 2020-06-30 13F AMGEN COM 031162100 6,166 -1,630 -20.91 1,454 -7.97 0.1602
2020-04-23 2020-03-31 13F AMGEN COM 031162100 7,796 0 0.00 1,580 -15.91 0.2051
2020-01-14 2019-12-31 13F AMGEN COM 031162100 7,796 -429 -5.22 1,879 18.03 0.1966
2019-10-10 2019-09-30 13F AMGEN COM 031162100 8,225 -896 -9.82 1,592 -5.29 0.1780
2019-07-18 2019-06-30 13F AMGEN COM 031162100 9,121 -586 -6.04 1,681 -8.84 0.1913
2019-04-11 2019-03-31 13F AMGEN COM 031162100 9,707 823 9.26 1,844 6.65 0.2187
2019-01-16 2018-12-31 13F AMGEN COM 031162100 8,884 -292 -3.18 1,729 -9.10 0.2233
2018-10-10 2018-09-30 13F AMGEN COM 031162100 9,176 80 0.88 1,902 13.28 0.2150
2018-07-13 2018-06-30 13F AMGEN COM 031162100 9,096 -105 -1.14 1,679 7.01 0.2001
2018-04-13 2018-03-31 13F AMGEN COM 031162100 9,201 1,204 15.06 1,569 12.80 0.1833
2018-01-16 2017-12-31 13F AMGEN COM 031162100 7,997 315 4.10 1,391 -2.86 0.1623
2017-10-13 2017-09-30 13F AMGEN COM 031162100 7,682 -1,825 -19.20 1,432 -12.52 0.1743
2017-07-14 2017-06-30 13F AMGEN COM 031162100 9,507 -395 -3.99 1,637 0.74 0.2071
2017-04-11 2017-03-31 13F AMGEN COM 031162100 9,902 3,734 60.54 1,625 80.16 0.2087
2017-01-12 2016-12-31 13F AMGEN COM 031162100 6,168 -7,155 -53.70 902 -59.42 0.1224
2016-10-12 2016-09-30 13F AMGEN COM 031162100 13,323 13,323 2,223 0.3022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.